Canada Joins Global Push To Drop Costly Clinical Trials For Biosimilars

 
• By Neena Brizmohun
Two Medicine Ampules And Canadian Flag
Health Canada is revising its guidance on submission requirements for biosimilar drugs (Shutterstock)

More from Regulation

More from Products